Evidence map›Paper›PMID 42653826›Full record

ReviewMolecules (Basel, Switzerland)2026

Unveiling Nanocellulose from the Perspective of Morphological Engineering.

Qian Zhang, Zitian Ding, Xin Wang, Jintian Huang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qian ZhangCollege of Material Science and Art Design, Inner Mongolia Agricultural University, Hohhot 010018, China.
Zitian DingCollege of Material Science and Art Design, Inner Mongolia Agricultural University, Hohhot 010018, China.
Xin WangCollege of Material Science and Art Design, Inner Mongolia Agricultural University, Hohhot 010018, China.
Jintian HuangCollege of Material Science and Art Design, Inner Mongolia Agricultural University, Hohhot 010018, China.

Funding

Inner Mongolia Autonomous Region Natural Science Foundation Project 2025MS03037Inner Mongolia Autonomous Region Science and Technology Program Project 2025KYPT0039the Science and Technology Plan Projects of Inner Mongolia Autonomous Region of China 2023YFHH0075
6 · The paper itself

Abstract

Green bioeconomy materials supported by biomass resources will undoubtedly be the next economic form. Nanocellulose is a carbon-containing renewable energy source that can replace fossil energy, and it can help alleviate the current dual pressure of environmental deterioration and energy shortage. With the rapid growth of nanocellulose in various application fields, the problem that different types of nanocellulose are better suited for different applications has emerged. This article starts with the morphological engineering of nanocellulose and establishes a line from the preparation method as the starting point to the application as the end point. When the starting point is the same, turning on different switches along the line will result in cellulose presenting different morphologies, thus corresponding to different endpoints. Our aim is to deeply explore the influence of this "regulation" in the preparation process on morphology, to discuss the inevitable relationship between different morphologies and applications, and to establish a causal relationship between different factors in a progressive manner. We hope to further the in-depth research on nanocellulose by deepening the understanding of the regulation and control strategies of the three-level structure of cellulose at the nanoscale and the design of functional characteristics.

Indexed as

applicationcontrolmorphologynanocellulose

Identifiers

PMID42653826
PMCPMC13515071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.